INTRODUCTION
Cancer is a disease caused by normal cells changing so that they grow in an uncontrolled way. Although many anti-tumor drugs and surgeries are available, the slow efficacy of the anti-tumor drugs and the cancer recurrence are still problems [1] [2] . In recent years, there were many small molecule anticancer drugs had been reported. Among them, 1-(4-bromo-2-fluorophenyl)-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one (1) is an significant intermediate for the synthesis of many biologically active compounds. Therefore, design and synthesis of 1-(4-bromo-2-fluorophenyl)-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one (1) derivative as small molecule inhibitors played a essential role in the study of anticancer.
Many 1-(4-bromo-2-fluorophenyl)-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one (1) derivatives which exhibited potential biological activities, such as 1-methyl-3-phenyl-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one(2) [3] , 1,8-dimethyl-1,3-dihydro-2H-imidazo [4,5-b] quinolin-2-one(3) [4] , 8-bromo-1-(2-chlorophenyl)-3-methyl-1,3-dihydro-2H-imidazo [4,5-c] quinolin-2-one(4) [5] , 4-(mesityloxy)-3,6-dimethyl-1-(pentan-3-yl)-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one(5) [6] , [4,5-c] quinolin-2-one (6) [7] , these 1-(4-bromo-2-fluorophenyl)-1,3-dihydro-2H-imidazo [4,5-c] pyridin-2-one (1) derivatives showed biological activity.
Most of the synthetic methods of 1-(4-bromo-2-fluorophenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (1) which reported in the literature have the drawbacks, such as complicated reaction conditions [8] . Pyridin-4-ol (7) 
MATERIALS AND METHODS
NMR spectrum were performed using Bruker 500 MHz spectrometers (Bruker Bioscience, Billerica,MA, USA) with TMS as an internal standard.Mass spectra (MS) were taken in ESI mode on Agilent 1100 LC-MS (Agilent, Palo Alto, CA, USA).All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254 (Qindao Haiyang Chemical).
SYNTHESIS OF COMPOUNDS
The structures and the synthetic route were shown in Scheme 1. 
3-NITROPYRIDIN-4-OL (8)
Pyridin-4-ol (10 g, 0.105 mol) is dissolved in conc. H2SO4 (60 mL) at 0 ℃. KNO3 (15 g, 0.149 mol) was added in portions over 10 minutes to the above solution and the reaction mixture is sequentially stirred for 10 hours at 110 ℃. The mixture is poured into 300 mL ice-water. The resulting precipitate is collected and washed with water thoroughly, dried and recrystallized from ether to give the pure product (9 g, yield 61% 
4-CHLORO-3-NITROPYRIDINE (9)
3-Nitropyridin-4-ol (8) (5.5 g, 0.0393 mol) was added to toluene (16 mL). The reaction flask was cooled to 0 degree and phosphoryl chloride (25 mL, 0.27 mol) was added dropwise. The mixture was blanketed with argon and heated to 110 degree for 2 h. Upon complete consumption of the precursor, as indicated by TLC, the mixture was cooled to room temperature and 100 mL of H2O was added. The mixture was then cooled to 0 degree, and the resulting brown solid was filtered. Recrystallization from ethanol gave yellow crystals (4. 
